CAS 272780-74-2

Metelimumab

CAS : 272780-74-2

A human IgG4 recombinant monoclonal antibody that can selectively neutralize TGFβ1.

Ref: 3D-CLA1151

Metelimumab

CAS : 272780-74-2

Metelimumab (CAT-192) is a humanised monoclonal antibody targeting TGFβ1, which can be used to study diffuse systemic sclerosis (d-SSc).

Degré de pureté : 95%

Couleur et forme : Liquid

Masse moléculaire : ~150 kDa

Ref: TM-T76819